Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
CSRT.L Share News (CSRT)
CSRT Share
Price
CSRT Share
News
CSRT Share
Chat
CSRT Share
Trades
CSRT
Live RNS
CSRT Share
Charts
CSRT Broker
Ratings
CSRT Directors
Deals
CSRT Financial
Diary
CSRT
Fundamentals
CSRT Short
Positions
CSRT
Media
CSRT Company
Research
CSRT Company
Timeline
- There is currently no data for CSRT
Monday broker round-up
Tate & Lyle: Berenberg reiterates hold with a target price of 810p.
Centrica: Berenberg reiterates hold with a target price of 85p.
Future: Berenberg reiterates buy with a target price of 1,830p.
ASOS: Berenberg upgrades to buy with a target price of 4,200p.
Royal Mail: Berenberg reiterates sell with a target price of 145p.
Celtic: Canaccord reiterates buy with a target price of 190p.
BT Group: Barclays reiterates underweight with a target price of 150p.
St James Place: Barclays reiterates overweight with a target price of 1,344p.
Prudential: Barclays reiterates overweight with a target price of 1,749p.
Phoenix Group Holdings: Barclays reiterates equal weight with a target price of 658p.
Legal & General Group: Barclays reiterates overweight with a target price of 347p.
Just Group: Barclays reiterates reiterates overweight with a target price of 66p.
Ashmore: UBS reiterates neutral with a target price of 540p.
Rolls Royce: Citigroup reiterates buy with a target price of 1,080p.
Burberry: Citigroup reiterates neutral with a target price of 2,240p.
Frontier Developments: Citigroup reiterates buy with a target price of 1,680p.
Ocado: JP Morgan reiterates underweight with a target price of 1,090p.
Vivo Energy: JP Morgan reiterates overweight with a target price of 160p.
Latest CSRT News
- Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition
17 Feb 2020 - Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional
4 Feb 2020 - Recipharm To Make No Further Changes To Consort Medical Offer
29 Jan 2020 - Recipharm Extends Consort Medical Offer Deadline To February 4
24 Jan 2020 - Recipharm Buys 10% Of Takeover Target Consort Medical
22 Jan 2020 - Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle
14 Jan 2020 - Friday broker round-up
10 Jan 2020
Related News
UK, Japan agree tech partnership and vow fighter jet progress
LONDON, June 14 (Reuters) - The leaders of Britain and Japan announced a tech partnership on Sunday designed to boost national security and create j...
UK, Japan set to agree $24 billion investment, tech partnerships
LONDON, June 13 (Reuters) - Britain and Japan are set to agree investment and technology partnerships worth more than £18 billion ($24 billion), e...
LONDON MARKET CLOSE: FTSE soars on peace hope as SpaceX IPO blasts off
(Alliance News) - The FTSE 100 ended the week on the front foot as Iran claimed a deal with the US has "never been closer", while investors were glued...
CSRT.L News
Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition
Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition
Monday broker round-up
(Sharecast News) - Consort Medical: RBC Capital Markets upgrades to sector performer with a target price of 1,010p.
Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional
Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional
Recipharm To Make No Further Changes To Consort Medical Offer
Recipharm To Make No Further Changes To Consort Medical Offer
Recipharm Extends Consort Medical Offer Deadline To February 4
Recipharm Extends Consort Medical Offer Deadline To February 4
Recipharm Buys 10% Of Takeover Target Consort Medical
Recipharm Buys 10% Of Takeover Target Consort Medical
Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle
Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle
Friday broker round-up
(Sharecast News) - Polymetal International: Berenberg upgrades to buy with a target price of 1,480p.
Follow the stocks
